The importance of inter-individual Kupffer cell variability in the governance of hepatic toxicity in a 3D primary human liver microtissue model

被引:0
作者
Ali Kermanizadeh
David M. Brown
Wolfgang Moritz
Vicki Stone
机构
[1] Heriot Watt University,
[2] School of Engineering and Physical Sciences,undefined
[3] Nano Safety Research Group,undefined
[4] InSphero AG,undefined
来源
Scientific Reports | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The potential for nanomaterial (NM) translocation to secondary organs is a realistic prospect, with the liver one of the most important target organs. Traditional in vitro or ex vivo hepatic toxicology models are often limiting and/or troublesome (i.e. short life-span reduced metabolic activity, lacking important cell populations, high inter-individual variability, etc.). Building on previous work, this study utilises a 3D human liver microtissue (MT) model (MT composed of mono-culture of hepatocytes or two different co-culture MT systems with non-parenchymal cell (NPC) fraction sourced from different donors) to investigate the importance of inter-donor variability of the non-parenchymal cell population in the overall governance of toxicological response following exposure to a panel of NMs. To the best of our knowledge, this is the first study of its kind to investigate inter-donor variability in hepatic NPC population. The data showed that the Kupffer cells were crucial in dictating the overall hepatic toxicity following exposure to the materials. Furthermore, a statistically significant difference was noted between the two co-culture MT models. However, the trend for particle-induced biological responses was similar between the co-cultures (cytotoxicity, cytokine production and caspase activity). Therefore, despite the recognition of some discrepancies in the absolute values between the co-culture models, the fact that the trends and patterns of biological responses were comparable between the multi-cellular models we propose the 3D liver MT to be a valuable tool in particle toxicology.
引用
收藏
相关论文
共 108 条
[1]  
Kermanizadeh A(2018)Nano delivery systems and stabilized solid drug nanoparticles for orally administered medicine - current landscape International Journal of Nanomedicine 13 7575-7605
[2]  
Powell L(2015)Nanotechnology in the real world: Redeveloping the nanomaterial consumer products inventory Beilstein Journal of Nanotechnology 6 1769-1780
[3]  
Stone V(2012)Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials with therapeutic and diagnosis applications Journal of Controlled Release 164 307-313
[4]  
Møller P(2015)Nanomaterial translocation - the biokinetics, tissue accumulation, toxicity and fate of materials in secondary organs - a review Critical Reviews of Toxicology 45 837-872
[5]  
Vance ME(2007)Health effects of nanomaterials Biochemical Society Transactions 35 527-531
[6]  
Johnston H(2009)Bio-distribution of gold nanoparticles in mouse lung following intratracheal instillation Chemistry Central Journal 3 2034-2042
[7]  
Brown D(2010)Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats Biomaterials 13 3980-3987
[8]  
Kermanizadeh A(2014)Toxicological impact of engineered nanomaterials on the liver - a review British Journal of Pharmacology 171 6574-6581
[9]  
Gubbins E(2013)Bio-persistence of silver nanoparticles in tissues from Sprague-Dawley rats Particle and Fibre Toxicology 10 1-151
[10]  
Stone V(2010)Bio-distribution of PEG-Modified gold nanoparticles following intratracheal instillation and intravenous injection Biomaterials 31 1315-1530